Use of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit

Objective: To describe failure modes and establish contingency measures related to the clinical medication process using medical prescriptions of patients admitted to an Intensive Respiratory Therapy Unit (UTIR), using the Failure Mode and Effects Analysis (FMEA) tool. Methods: This is a descriptiv...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kamila M. SIDNEY, Elana F. CHAVES, Henrique M. COSTA, Geysa A. ROMEU, Marta F. FONTELES
Formato:	article
Lenguaje:	EN PT
Publicado:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2021
Materias:	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/d89434d46e52459e97d46b9c8c24e0fa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d89434d46e52459e97d46b9c8c24e0fa
record_format	dspace
spelling	oai:doaj.org-article:d89434d46e52459e97d46b9c8c24e0fa2021-11-28T02:42:47ZUse of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit10.30968/rbfhss.2021.123.06062179-59242316-7750https://doaj.org/article/d89434d46e52459e97d46b9c8c24e0fa2021-07-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/606https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Objective: To describe failure modes and establish contingency measures related to the clinical medication process using medical prescriptions of patients admitted to an Intensive Respiratory Therapy Unit (UTIR), using the Failure Mode and Effects Analysis (FMEA) tool. Methods: This is a descriptive and cross-sectional study carried out in an Intensive Care Unit of a public hospital in Fortaleza, Brazil, from November/2015 to March/2016. Study population included adults aging ≥ 18 years in intensive care at the UTIR. The study included the medical prescriptions released on Mondays, Wednesdays, and Fridays. The study was divided in five phases: situational diagnosis, formation of a multiprofessional team, assessment of failure modes (FM), monitoring of FM and calculation of the priority coefficient (PC). In the FM assessment, scoring of the three indicators of the FMEA was used within a range of 1-10, whereas a score of 10 characterized the most concerning situation. Therefore, the indicators gravity (G), prevalence (P) and detection (D) were analyzed. The study was carried out with an active interaction between the subjects of the group and several in-person and virtual sessions were performed. Drugs used in the study were categorized for therapeutic class, according to the Anatomical Therapeutic Chemical Classification System. Data analysis was performed using Microsoft Office Excel® 2013 software. Results: 301 prescriptions were analyzed, with the identification of 452 FMs, which related mostly to systemic antibacterials (21.6%, n = 8), psycholeptics (13.5%, n = 5) and antithrombotic agents (10.8%, n = 4). FMs were divided in eleven categories, from which “drug interaction” (36.8%; n = 14), “dose adjustment” (21.1%, n = 8) and “food-drug interaction” (7.9%, n = 3) were the most frequent. The PC of the detected FMs varied between 28 and 294, and 42.1% (n = 16) of them presented PC above 100. Median of the indicators G (6 – min: 3; max: 9), D (7 – min: 3; max 7) and priority coefficient (72 – min: 28; max: 294) indicate that FM had generally moderate gravity, low prevalence and low detection. For the majority of FMs (72.7%, n = 28), the chosen conduct was ‘not to accept’ and the established contingency measure included a sentinel event notification. Conclusion: The use of FMEA enabled the identification, classification, and prioritization of risks of the clinical medication process in the UTIR. This study indicates the need to implement measures that increase safety in the clinical practice of the study Intensive Care Unit. Kamila M. SIDNEYElana F. CHAVESHenrique M. COSTAGeysa A. ROMEUMarta F. FONTELESSociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdearticlePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 12, Iss 3 (2021)
institution	DOAJ
collection	DOAJ
language	EN PT
topic	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
spellingShingle	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950 Kamila M. SIDNEY Elana F. CHAVES Henrique M. COSTA Geysa A. ROMEU Marta F. FONTELES Use of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit
description	Objective: To describe failure modes and establish contingency measures related to the clinical medication process using medical prescriptions of patients admitted to an Intensive Respiratory Therapy Unit (UTIR), using the Failure Mode and Effects Analysis (FMEA) tool. Methods: This is a descriptive and cross-sectional study carried out in an Intensive Care Unit of a public hospital in Fortaleza, Brazil, from November/2015 to March/2016. Study population included adults aging ≥ 18 years in intensive care at the UTIR. The study included the medical prescriptions released on Mondays, Wednesdays, and Fridays. The study was divided in five phases: situational diagnosis, formation of a multiprofessional team, assessment of failure modes (FM), monitoring of FM and calculation of the priority coefficient (PC). In the FM assessment, scoring of the three indicators of the FMEA was used within a range of 1-10, whereas a score of 10 characterized the most concerning situation. Therefore, the indicators gravity (G), prevalence (P) and detection (D) were analyzed. The study was carried out with an active interaction between the subjects of the group and several in-person and virtual sessions were performed. Drugs used in the study were categorized for therapeutic class, according to the Anatomical Therapeutic Chemical Classification System. Data analysis was performed using Microsoft Office Excel® 2013 software. Results: 301 prescriptions were analyzed, with the identification of 452 FMs, which related mostly to systemic antibacterials (21.6%, n = 8), psycholeptics (13.5%, n = 5) and antithrombotic agents (10.8%, n = 4). FMs were divided in eleven categories, from which “drug interaction” (36.8%; n = 14), “dose adjustment” (21.1%, n = 8) and “food-drug interaction” (7.9%, n = 3) were the most frequent. The PC of the detected FMs varied between 28 and 294, and 42.1% (n = 16) of them presented PC above 100. Median of the indicators G (6 – min: 3; max: 9), D (7 – min: 3; max 7) and priority coefficient (72 – min: 28; max: 294) indicate that FM had generally moderate gravity, low prevalence and low detection. For the majority of FMs (72.7%, n = 28), the chosen conduct was ‘not to accept’ and the established contingency measure included a sentinel event notification. Conclusion: The use of FMEA enabled the identification, classification, and prioritization of risks of the clinical medication process in the UTIR. This study indicates the need to implement measures that increase safety in the clinical practice of the study Intensive Care Unit.
format	article
author	Kamila M. SIDNEY Elana F. CHAVES Henrique M. COSTA Geysa A. ROMEU Marta F. FONTELES
author_facet	Kamila M. SIDNEY Elana F. CHAVES Henrique M. COSTA Geysa A. ROMEU Marta F. FONTELES
author_sort	Kamila M. SIDNEY
title	Use of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit
title_short	Use of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit
title_full	Use of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit
title_fullStr	Use of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit
title_full_unstemmed	Use of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit
title_sort	use of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit
publisher	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate	2021
url	https://doaj.org/article/d89434d46e52459e97d46b9c8c24e0fa
work_keys_str_mv	AT kamilamsidney useofthefailuremodeandeffectanalysistoolintheclinicalmedicationprocessinanintensivecareunit AT elanafchaves useofthefailuremodeandeffectanalysistoolintheclinicalmedicationprocessinanintensivecareunit AT henriquemcosta useofthefailuremodeandeffectanalysistoolintheclinicalmedicationprocessinanintensivecareunit AT geysaaromeu useofthefailuremodeandeffectanalysistoolintheclinicalmedicationprocessinanintensivecareunit AT martaffonteles useofthefailuremodeandeffectanalysistoolintheclinicalmedicationprocessinanintensivecareunit
_version_	1718408469332099072

Use of the failure mode and effect analysis tool in the clinical medication process in an intensive care unit

Ejemplares similares